Biotech Values

[DewDiligence]

IDIX Insider Transactions During Past 24 Months

[Added recent purchases by Hodgson and Weidenbruch.
See #msg-44704491 for current insider shareholdings.]


OPTION EXERCISE and HOLD

David Standring, EVP Biology
11-Nov-2009 15,000 options exercised @$1.00 and held (#msg-43558137)


PURCHASES

Thomas Hodgson, Director
10-16-Dec-2009 50,000 shares @2.05-2.15

John Weidenbruch, Gen Counsel
24-Nov-2009 20,000 shares @1.89
11-Mar-2008 15,000 shares @4.52-4.59

Ron Renaud, CFO
11-Mar-2008 15,000 shares @4.50-4.55

Doug Mayers, CMO
11-Mar-2008 30,000 shares @4.45


SALE

JP Sommadossi, CEO
*16-Sep-2008 110,000 shares @8.00

*Transfer of shares to University of Alabama (Birmingham)
pursuant to a previously announced legal settlement.


SEC links:
http://sec.gov/Archives/edgar/data/1093649/000120919109057544/xslF345X03/doc4.xml
http://sec.gov/Archives/edgar/data/1093649/000120919109056948/xslF345X03/doc4.xml
http://sec.gov/Archives/edgar/data/1093649/000120919109054215/xslF345X03/doc4.xml
http://sec.gov/Archives/edgar/data/1093649/000120919109052601/xslF345X03/doc4.xml
http://sec.gov/Archives/edgar/data/1093649/000120919108052275/xslF345X03/doc4.xml
http://www.sec.gov/Archives/edgar/data/1093649/000120919108017195/xslF345X02/doc4.xml
http://www.sec.gov/Archives/edgar/data/1093649/000120919108017843/xslF345X02/doc4.xml
http://www.sec.gov/Archives/edgar/data/1093649/000120919108017844/xslF345X02/doc4.xml
http://www.sec.gov/Archives/edgar/data/1093649/000120919106029333/xslF345X02/doc4.xml